Ursodeoxycholic acid counteracts celecoxib in reduction of duodenal polyps in patients with familial adenomatous polyposis: a multicentre, randomized controlled trial

Heumen, B.W.H. van; Roelofs, H.M.J.; Vink-Borger, M.E.; Dekker, E.; Mathus-Vliegen, E.M.H.; Dees, J.; ... ; Nagengast, F.M. (2013)

Article / Letter to editor

• Familial adenomatous polyposis
• Chemoprevention
• Celecoxib
• Ursodeoxycholic acid
• Duodenal adenomatosis
• Cell proliferation
• Apoptosis
• Cyclooxygenase-2

• All authors: Heumen, B.W.H. van; Roelofs, H.M.J.; Vink-Borger, M.E.; Dekker, E.; Mathus-Vliegen, E.M.H.; Dees, J.; Koornstra, J.J.; Langers, A.M.J.; Nagtegaal, I.D.; Kampman, E.; Peters, W.H.M.; Nagengast, F.M.
• Date: 2013-08-06
• Journal: Orphanet Journal of Rare Diseases
• Volume: 8
• DOI: doi:10.1186/1750-1172-8-118